Brought to you by 
Kent to sell Verex's verapamil in the UK & Ireland
04 Jun 1999
Executive Summary
Kent Pharmaceuticals and Verex Laboratories signed an exclusive licensing agreement for the sale and distribution of Verex's sustained release verapamil (treats hypertension, angina and certain cardiac arrythmias) in England and Ireland.
Deal Industry
- Pharmaceuticals
Deal Status
Deal Type
-
Alliance
- Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com